Biotech

All Articles

GSK's long-acting bronchial asthma drug cut in half attacks in phase 3

.GSK's long-acting asthma treatment has been revealed to halve the lot of attacks in a set of phase ...

AstraZeneca, Daiichi unpack Dato-DXd's overall survival neglect

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has neglected to boos...

Roivant reveals brand new 'vant' to accelerate Bayer high blood pressure med

.Matt Gline is back along with a new 'vant' business, after the Roivant Sciences CEO paid Bayer $14 ...

Viridian eye illness period 3 hits, advancing push to rivalrous Amgen

.Viridian Rehabs' phase 3 thyroid eye condition (TED) clinical test has struck its own major and als...

Bain introduces $3B fund permanently science companies

.Along with a sturdy track record for identifying rough diamonds, Bain Financing Life Sciences (BCLS...

Genentech's cancer cells restructure brought in 'for scientific reasons'

.The latest selection to merge Genentech's two cancer cells divisions was created "clinical factors,...

Tern dental GLP-1 shows 5% weight reduction at 1 month at highest dose

.Terns Pharmaceuticals' choice to fall its liver ailment ambitions may however pay, after the biotec...

Merck, Daiichi replay early success in little tissue bronchi cancer cells along with updated ADC records

.Merck &amp Co.'s long-running initiative to land a punch on tiny cell bronchi cancer (SCLC) has rac...

Boehringer, Bayer advance bronchi cancer medicines towards Astra war

.Some people with non-small cell lung cancer (NSCLC) have anomalies in a genetics called individual ...

MBX aims for $136M IPO to take opponent to Ascendis into period 3

.MBX has actually elaborated plannings to consume over $136 thousand from its own IPO as the biotech...